Reply: 18F-FDG uptake to assess eosinophilic inflammation in asthma: Would SUV at late imaging be relevant?

Journal of Nuclear Medicine

Volumn 53, Issue 8, 2012, Pages 1328-1329

  Harris, R Scott ^a   Winkler, Tilo ^b   Venegas, Jose G ^b   Medoff, Benjamin ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; DILUENT; FLUORODEOXYGLUCOSE F 18;

ASTHMA; BLOOD SAMPLING; CALIBRATION; DRUG UPTAKE; EOSINOPHIL COUNT; EOSINOPHILIC INFLAMMATION; IMAGE ANALYSIS; INFLAMMATION; LETTER; LUNG BLOOD VOLUME; LUNG LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STANDARD UPTAKE VALUE; VENOUS BLOOD; ANIMAL; EOSINOPHIL; FEMALE; HUMAN; IMMUNOLOGY; MALE; METABOLISM; NOTE; RESPIRATORY SYSTEM;

ANIMALS; ASTHMA; EOSINOPHILS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; RESPIRATORY SYSTEM;

EID: 84864756603     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.104018     Document Type: Letter

References (2)

1. 18F-FDG uptake rate is a biomarker of eosinophilic inflammation and airway response in asthma. J Nucl Med. 2011;52:1713-1720.
2. 18F-FDG uptake by the inflamed lung. J Nucl Med. 2007;48:1889-1896.